New York, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Overview
The Global Cholesterol Testing Market is projected to reach USD 109.8 billion in 2024 which is further anticipated to reach USD 247.5 billion by 2033 at a CAGR of 9.4%.
The global cholesterol testing market is rapidly growing as people become more conscious about cardiovascular health and its testing needs. Cholesterol tests play a vital role in identifying risk for heart disease, stroke, and dementia in an aging population; advances such as biosensors and point-of-care devices enhance accuracy and convenience to drive market expansion; government efforts focused on cardiovascular wellness are another factor driving market expansion;
North America leads this expansion with higher healthcare spending per person followed by Europe and Asia/Pacific regions.
Click to Request Sample Report and Drive Impactful Decisions: https://dimensionmarketresearch.com/report/cholesterol-testing-market/request-sample/
The US Cholesterol Testing Market
The US cholesterol testing market, expected to reach USD 76.9 billion by 2033 at an average compound annual growth rate of 8.8% from USD 35.9 billion in 2024, will be driven by trends including an increasing focus on point-of-care testing devices and home health diagnostics, advances in biosensors and digital strips to enhance detection as well as rising concerns surrounding high cholesterol and cardiovascular complications, screening programs with healthcare organizations expanding access, user experience improvement and effectiveness improvements of testing services provided.
Important Insights
- Market Size: The Global Cholesterol Testing Market size is estimated to have a value of USD 109.8 billion in 2024 and is expected to reach USD 247.5 billion by the end of 2033.
- The US Market Size: The US Cholesterol Testing market is projected to be valued at USD 35.9 billion in 2024. It is expected to witness subsequent growth in the upcoming period as it holds USD 76.9 billion in 2033 at a CAGR of 8.8%.
- By Product Segment Analysis: Test strips are now projected to dominate the global cholesterol testing market as they hold 37.1% of the market share in 2024.
- By Test Type Segment: High-density lipoprotein cholesterol tests are anticipated to capture a 33.2% market share in 2024.
- Regional Analysis: North America is expected to have the largest market share in the Global Cholesterol Testing Market with a share of about 38.9% in 2024.
- Global Growth Rate: The market is growing at a CAGR of 8.8 % over the forecasted period.
Latest Trends
- Trends towards Telehealth for Cholesterol Management: Telehealth services have increasingly become part of cholesterol testing regimens, enabling individuals to monitor levels remotely while receiving expert guidance remotely from any location. Telemedicine allows continual cholesterol management without frequent clinic visits another benefit post-pandemic due to acceptance.
- Shift to Preventive Healthcare: Healthcare has increasingly moved towards preventive measures, emphasizing early identification and management of elevated cholesterol levels through regular screenings. Health awareness campaigns inform the public about this important aspect of healthcare that could save their life later on.
Cholesterol Testing Market: Competitive Landscape
Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers are leading global cholesterol testing markets with innovative, accurate, comfortable testing technologies through R&D investments in R&D; other companies like emerging players or startups are contributing with new home testing kits or point-of-care devices as well.
Strategic collaborations between diagnostic companies and healthcare providers as well as geographical expansion strategies along with strong distribution networks often contribute to competitive differentiation within this space while technological innovations, frequent product releases, and better accessibility and affordability enhance its competitive edge even further.
Some of the prominent market players:
- Abbott Laboratories
- Sigma-Aldrich Corp.
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- Boston Heart Diagnostics Corporation
- Eurofins Scientific
- Hoffmann-La Roche Ltd.
- AccuTech LLC
- Akers Biosciences Inc.
- Home Access Health Corporation
- Laboratory Corporation of America Holdings
- PTS Diagnostics
- Other Key Players
Transform your business approach with strategic insights from our report. Get in touch to request our brochure today! : https://dimensionmarketresearch.com/report/cholesterol-testing-market/download-reports-excerpt/
Cholesterol Testing Market Scope
| Report Highlights | Details |
| Market Size (2024) | USD 109.8 Bn |
| Forecast Value (2033) | USD 247.5 Bn |
| CAGR (2024-2033) | 9.4% |
| North America Revenue Share | 38.9% |
| The US Market Size (2024) | USD 35.9 Bn |
| Historical Data | 2018 - 2023 |
| Forecast Data | 2024 - 2033 |
| Base Year | 2023 |
| Estimate Year | 2024 |
| Segments Covered | By Product Type, By Test Type, By Technology, By End User |
| Regional Coverage | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Market Analysis
Test strips are expected to command 37.1% of the global cholesterol testing market by 2024 due to their affordability, simplicity, and wide availability. Single-use strips are popular at home because they're easy and user-friendly compared with professional help; multi-use and digital strips gain popularity for accuracy as well as minimal training requirements - popular both at home care facilities as well as clinics.
Due to the low costs associated with preventive healthcare initiatives and early diagnosis testing strategies; test strips remain globally sought-after products.
Cholesterol Testing Market Segmentation
By Product Type
- Test Strips
- Single-Use Test Strips
- Multi-Use Test Strips
- Digital Test Strips
- Test Kits
- Home Test Kits
- Professional Test Kits
- Point-of-Care Test Kits
- Laboratory Test Kits
- Test Meters
- Other Product Types
By Test Type
- High-density lipoprotein (HDL) Cholesterol
- Direct HDL Tests
- Homogeneous HDL Tests
- Low-density lipoprotein (LDL) Cholesterol
- Direct LDL Tests
- Homogeneous LDL Tests
- Total Cholesterol Test
- Enzymatic Total Cholesterol Tests
- Chemical Total Cholesterol Tests
- Triglycerides/VLDL Cholesterol Test
- Direct Triglycerides Tests
- VLDL Calculated Tests
- Other Test Types
By Technology
- Biosensors
- Electrochemical Biosensors
- Optical Biosensors
- Spectrometry
- Mass Spectrometry
- UV-Vis Spectrometry
- Chromatography
- Gas Chromatography
- Liquid Chromatography
By End User
- Hospitals
- Diagnostic Centers
- Others
Purchase the Competition Analysis Dashboard Today: https://dimensionmarketresearch.com/checkout/cholesterol-testing-market/
Growth Drivers
- Technological Advancements in Testing Devices: Innovations in cholesterol testing technologies such as advanced biosensors and portable point-of-care devices have greatly increased accuracy, convenience, and accessibility - meeting healthcare providers' and patients' evolving needs while driving market expansion.
- Government Initiatives and Health Programs: Government initiatives and health organization programs such as subsidies, public awareness campaigns, and regular checkups help drive demand for cholesterol testing products and services by responding to an increase in cardiovascular disease cases.
Restraints
- Economic Barriers in Low-Income Regions: High costs associated with advanced cholesterol testing devices limit their availability in lower-income regions, restricting market expansion while emphasizing the need for cost-cutting alternatives.
- Variability in Test Accuracy: Uneven cholesterol testing methods can undermine their reliability, so standardizing and quality are integral parts of building trust with cholesterol-testing products.
Growth Opportunities
- Expansion into Emerging Markets: Companies expanding in these emerging markets to meet rising cholesterol testing demands will find growth opportunities here. Increased awareness about healthcare issues, improved infrastructure, and rising incomes all play a part.
- Innovative Home Testing Solutions Development: With home healthcare becoming more of a consumer trend, innovative home cholesterol test kits present opportunities. Offering convenience, privacy, and regular monitoring - appealing to health-minded consumers is what drives their popularity.
Regional Analysis
North America is projected to dominate the cholesterol testing market with a 38.9% revenue share by 2024, driven by high cardiovascular disease prevalence rates, advanced healthcare infrastructure development initiatives, and government initiatives promoting regular monitoring.
Major players like Abbott Laboratories and Quest Diagnostics provide market support; with their technological innovations supporting market expansion. Aging populations, high healthcare spending levels, and preventive care focus further augment market growth in this region; government initiatives targeting cardiovascular disease burden reduction while raising cholesterol management awareness also contribute towards the dominance of this region in the cholesterol testing market.
By Region
North America
- The U.S.
- Canada
Europe
- Germany
- The U.K.
- France
- Italy
- Russia
- Spain
- Benelux
- Nordic
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- ANZ
- ASEAN
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Egypt
- Rest of MEA
Discover additional reports tailored to your industry needs
- Proteomics Market size is expected to reach a value of USD 27.0 billion in 2024, and it is further anticipated to reach a market value of USD 92.8 billion by 2033 at a CAGR of 14.7%.
- Predictive Disease Analytics Market is expected to reach a value of USD 2.6 billion in 2024, and it is further anticipated to reach a market value of USD 19.2 billion by 2033 at a CAGR of 24.7%.
- Precision Medicine Market is expected to reach a value of USD 83.9 billion in 2024, and it is further anticipated to reach a market value of USD 225.7 billion by 2033 at a CAGR of 11.6%.
- Pharmaceutical Intermediates Market size is expected to reach a value of USD 44.9 billion in 2024, and it is further anticipated to reach a market value of USD 90.4 billion by 2033 at a CAGR of 8.1%.
- Next Generation Cancer Diagnostics Market size is expected to reach a value of USD 19.1 billion in 2024, and it is further anticipated to reach a market value of USD 47.2 billion by 2033 at a CAGR of 10.6%.
- mHealth Market size is expected to reach a value of USD 75.2 billion in 2024, and it is further anticipated to reach a market value of USD 210.8 billion by 2033 at a CAGR of 12.1%.
- Medical Plastic Compound Market is expected to dominate with USD 60.8 billion in 2024 and is anticipated to grow to USD 119.4 billion by 2033 at a CAGR of 7.8%.
- Personalized Medicine Biomarker Market size is expected to reach a value of USD 17.0 billion in 2024, and it is further anticipated to reach a market value of USD 72.7 billion by 2033 at a CAGR of 17.5%.
- Nutraceutical Excipients Market size is expected to reach a value of USD 5.2 billion in 2024, and it is further anticipated to reach a market value of USD 10.0 billion by 2033 at a CAGR of 7.6%.
Recent Developments in the Cholesterol Testing Market
- July 2024: Abbott Laboratories launched a new digital cholesterol test strip, enhancing convenience and accuracy for home monitoring. It integrates with mobile health apps for tracking and data sharing with healthcare providers.
- June 2024: Roche Diagnostics introduced an advanced point-of-care cholesterol testing device with the latest biosensor technology, offering rapid and precise real-time results for clinical decision-making.
- May 2024: Siemens Healthineers partnered with Ascension Health to expand cholesterol testing services in underserved regions via mobile units and telehealth, improving healthcare equity.
- April 2024: BioTech Innovations unveiled a biosensor-based home cholesterol test kit with smartphone integration for quick, reliable results and proactive health management.
- March 2024: Johns Hopkins University researchers published a study on a new optical biosensor technology for cholesterol testing, promising enhanced accuracy and commercial potential.
- February 2024: Quest Diagnostics launched a comprehensive cholesterol management platform, including testing devices and a digital health app for monitoring, personalized recommendations, and professional support.
- January 2024: Kaiser Permanente introduced a community health initiative with free cholesterol screening camps, educational workshops, and home test kit distribution to promote routine monitoring.
Click to Request Sample Report and Drive Impactful Decisions: https://dimensionmarketresearch.com/report/cholesterol-testing-market/request-sample/
About Dimension Market Research (DMR):
Dimension Market Research (DMR) is a market research and consulting firm based in India & US, with its headquarters located in the USA (New York). The company believes in providing the best and most valuable data to its customers using the best resources analysts work, to create unmatchable insights into the industries, and markets while offering in-depth results of over 30 industries, and all major regions across the world.
We also believe that our clients don’t always want what they see, so we provide customized reports as well, as per their specific requirements to create the best possible outcomes for them and enhance their business through our data and insights in every possible way.
